HD (50 mg/kg) relieved liver fibrosis by reducing TBARS formation and caspase-3 activation and inhibiting the expression of NF-κB, TGF-β and connective tissue growth factor (CTGF) in the CCl4-induced fibrotic model [61, 62]. Here, TGFB1 is linked to Hepatic fibrosis.